PI
Amsterdam institute for Immunology and Infectious diseases
-
Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies
Veenstra, C. R., Ngai, L. L., Gradowska, P., Versluis, J., Reuvekamp, T., Kelder, A., Scholten, W., Snel, S., Tettero, J. M., Bachas, C., Breems, D. A., Fischer, T., Gjertsen, B. T., Griskevicius, L., Juliusson, G., Maertens, J. A., Manz, M. G., Pabst, T., Passweg, J. R. & Porkka, K. & 7 others, , May 2026, In: HemaSphere. 10, 5, e70379.Research output: Contribution to journal › Article › Academic › peer-review
-
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party
Cloos, J., Valk, P. J. M., Thiede, C., Döhner, K., Roboz, G. J., Wood, B. L., Walter, R. B., Wang, S., Wierzbowska, A., Wei, A. H., Wu, D., Vergez, F., Venditti, A., van der Reijden, B. A., van de Loosdrecht, A. A., Tiong, I. S., Thol, F. R., Subklewe, M., Roumier, C. & Reuvekamp, T. & 26 others, , 12 Mar 2026, In: Blood. 147, 11, p. 1147-1167 21 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities
Boertjes, E. L., Grob, T., Al Hinai, A., Beverloo, B. H. B., Versluis, J., Kavelaars, F. G., Rijken, M., Compagne, K. G., Erpelinck, C. A. J., Sanders, M. A., Stoetman, E. C. G., Hanekamp, D., Gradowska, P. L., Ossenkoppele, G. J., Biemond, B. J., Manz, M. G., Pabst, T., Jongen-Lavrencic, M., löwenberg, B. & Valk, P. J. M., 24 Feb 2026, In: Blood. 10, 4, p. 939-950 12 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications